5,6-MeO-MiPT
Chemical compound
From Wikipedia, the free encyclopedia
5,6-MeO-MiPT, also known as 5,6-dimethoxy-N-methyl-N-isopropyltryptamine, is a chemical compound of the tryptamine family.[1] It is the 5,6-dimethoxy derivative of methylisopropyltryptamine (MiPT) and is an analogue of 5-MeO-MiPT.[1] In his 1991 book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin listed the dose as greater than 75 mg orally and the duration as unknown.[1] The drug produced few to no effects at doses of up to 75 mg orally.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MeO-MiPT.[1] However, the drug has been found to have abolished or profoundly reduced affinities for serotonin receptors compared to psychedelic tryptamines like MiPT and 5-MeO-MiPT.[2] Its chemical synthesis has been described.[1] 5,6-MeO-MiPT was first described in the scientific literature by David Repke and Alexander Shulgin and colleagues.[3]
- None
| Clinical data | |
|---|---|
| Other names | 5,6-Dimethoxy-N-methyl-N-isopropyltryptamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonin receptor modulator |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | Unknown[1] |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H24N2O2 |
| Molar mass | 276.380 g·mol−1 |
| 3D model (JSmol) | |
| |
| |